Eculizumab is a long-acting, humanized monoclonal antibody that specifically targets complement component C5. By inhibiting the cleavage of C5 into C5a and C5b, Eculizumab effectively prevents the activation of the terminal complement system, including the formation of the membrane attack complex (MAC). This antibody is particularly useful in research focused on hemolysis and other conditions related to complement system dysregulation.
Eculizumab is a long-acting, humanized monoclonal antibody that specifically targets complement component C5. By inhibiting the cleavage of C5 into C5a and C5b, Eculizumab effectively prevents the activation of the terminal complement system, including the formation of the membrane attack complex (MAC). This antibody is particularly useful in research focused on hemolysis and other conditions related to complement system dysregulation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: